Skip to main content
European Network of Centres for Pharmacoepidemiology and Pharmacovigilance
News article1 October 2010European Medicines Agency

European Medicines Agency awards first 'ENCePP study' seal for post-marketing study

The European Medicines Agency and the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) have awarded the first 'ENCePP study' seal to an observational study investigating the "long-term outcomes and adverse events of therapy with inhaled corticosteroids, long-acting beta-2-agonists and anticholinergic drugs in hospitalised patients with Chronic Obstructive Pulmonary Disease (COPD)".

The study is coordinated by the Department of Epidemiology, Lazio Regional Health Service.

For further information see: Press release published on 1st October 2010

Details

Publication date
1 October 2010
Author
European Medicines Agency